• Report an Adverse Event
• Contact Us
• Send Link

This site is intended for European Healthcare Professionals only. Otherwise see Public Site

• Home
• Product Finder
  • GSK Product Name
  • Generic Product Name

  More options

  • Arixtra®▼ (Fondaparinux sodium)
  • Arzerra®▼ (ofatumumab)
  • Atriance® (nelarabine)
  • Avamys®▼ (Fluticasone Furoate)
  • Avodart® (dutasteride)
  • Benlysta®▼ (belimumab)
  • Combodart™▼ (0.5 mg dutasteride / 0.4 mg tamsulosin hydrochloride)
  • Duodart™▼ (0.5 mg dutasteride / 0.4 mg tamsulosin hydrochloride)
  • Hycamtin®▼ (topotecan)
  • ReQuip®LP (ropinirole hydrochloride prolonged-release tablets)
  • ReQuip® PD (ropinirole hydrochloride prolonged-release tablets)
  • ReQuip®XL (ropinirole hydrochloride prolonged-release tablets)
  • ReQuip Depot® (ropinirole hydrochloride prolonged-release tablets)
  • ReQuip Modutab™ (ropinirole hydrochloride prolonged-release tablets)
  • ReQuip Prolib™ and ReQuip® prolonged-release tablets (ropinirole hydrochloride prolonged-release tablets)
  • Revolade®▼ (eltrombopag)
  • Seretide® (salmeterol xinafoate/fluticasone propionate)
  • Trobalt™▼ (Retigabine)
  • Tyverb®▼ (lapatinib)
  • Viani® (salmeterol xinafoate/fluticasone propionate)
  • Votrient®▼ (pazopanib)

  • belimumab (Benlysta®▼)
  • dutasteride (Avodart®)
  • eltrombopag (Revolade®▼)
  • Fondaparinux sodium (Arixtra®▼)
  • Fluticasone Furoate (Avamys®▼)
  • lapatinib (Tyverb®▼)
  • nelarabine (Atriance®)
  • ofatumumab (Arzerra®▼)
  • pazopanib (Votrient™▼)
  • ropinirole hydrochloride prolonged-release tablets (ReQuip Modutab™, also known as  ReQuip®LP, ReQuip® PD, ReQuip®XL, ReQuip Depot®, ReQuip Prolib™ and ReQuip® prolonged-release tablets)
  • Retigabine (Trobalt™▼)
  • salmeterol xinafoate/fluticasone propionate (Seretide®, also known as  Viani®)
  • topotecan (Hycamtin®▼)
• Therapy Areas
  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory and Allergy
  • Urology
  • Immunology
• News
• Media and Resources

Informing European Healthcare Professionals on our products

This site contains information on our European products, including prescribing and safety information. Regular updates to this site will be made with the latest product news to enhance the information available to you. You can search this site via products or therapy areas.

• 

  Welcome to health.gsk

  health.gsk is the European GSK website providing on licence online product-related information for both healthcare professionals and members of the public

SF: Last updated 01 February 2011: DICE/MARK/0005a/10

Our Therapy Areas

• Cardiovascular
• Neurology
• Oncology
• Respiratory and Allergy
• Urology
• Immunology